Interim Safety Analysis Of The Dante Trial: Perioperative Atezolizumab In Combination With Flot Versus Flot Alone In Patients With Resectable Esophagogastric Adenocarcinoma-A Randomized, Open-Label Phase Ii Trial Of The German Gastric Group At The Aio And Sakk.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
4549Background: The DANTE study evaluates atezolizumab in the perioperative treatment of locally advanced, potentially resectable gastric or GEJ adenocarcinoma in combination with perioperative FLO...
更多查看译文
关键词
perioperative atezolizumab,resectable esophagogastric adenocarcinoma—a,dante trial,german esophagogastric group,flot,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要